American Society of Hirudotherapy

Antibiotic and heavy metal resistance genes in Aeromonas spp. isolated from marketed Manila Clam (Ruditapes philippinarum) in Korea

Research article published in Journal of applied microbiology (2019)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportAntimicrobial ResistanceDahanayake et al. · Journal of applied microbiology, 2019

Abstract

AIMS: Manila clam (Ruditapes philippinarum) is one of the most popular seafood in Korea, owing to their unique taste and nutritional value. This study aimed to disclose the antibiotic and heavy metal resistance characteristics of Aeromonas spp. isolated from marketed Manila clam in Korea. METHODS AND RESULTS: A total of 36 Aeromonas spp. strains were isolated and subjected to two tests: an antibiotic disk diffusion test to determine their resistance to antibiotics, and a broth dilution test to determine their resistance to heavy metals. PCR-based amplification was performed to detect the resistance genes. A high level of resistance to ampicillin (100%) and cephalothin (89%) was observed, while 42, 39, 36 and 36% of the isolates were resistant to oxytetracycline, imipenem, nalidixic acid and tetracycline respectively. In addition, among the tested heavy metals, cadmium (Cd) recorded the highest resistance rate (61%), followed by chromium (Cr) (50%), lead (Pb) (47%) and copper (Cu) (37%). However, mercury (Hg) resistance was not observed. PCRs revealed the occurrence of blaTEM , blaSHV , blaCTX-M , qnrS, tetB, tetE, aac(6')-Ib, strA-strB and intI1 genes among 100, 31, 31, 78, 78, 89, 25, 50 and 72% of the isolates respectively. Moreover, heavy metal resistance genes, copA, merA and czcA were detected in 25, 47 and 61% of the isolates respectively. CONCLUSIONS: The results suggest the importance of multi-drug and heavy metal-resistant aeromonads in Manila clam to assess the consumer safety and public health. SIGNIFICANCE AND IMPACT OF THE STUDY: This study is the first to elaborate on the importance of multi-drug and heavy metal-resistant aeromonads in Manila clam. Particularly, the presence of extended-spectrum-β-lactamase genes and other antibiotic resistance genes intensifies the possible health risks and may complicate therapeutic treatments upon infection, while heavy metal resistance suggests possible heavy metal exposure.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAeromonasAnimalsAnti-Bacterial AgentsBivalviaDrug Resistance, MicrobialHumansMetals, HeavyPolymerase Chain ReactionRepublic of Korea

Summary

Peer-reviewed research on antimicrobial resistance relevant to Aeromonas and leech-associated infection. Indexed in PubMed and verified against the NCBI record.

Why This Matters for Hirudotherapy

This microbiological surveillance study isolated 36 Aeromonas strains from marketed Manila clams in Korea and characterized their resistance, finding universal ampicillin resistance (100%) and high cephalothin resistance (89%), variable resistance to oxytetracycline, imipenem, nalidixic acid and tetracycline, plus extended-spectrum beta-lactamase genes (blaTEM in 100%, blaSHV and blaCTX-M each 31%) and heavy-metal resistance genes. Although the source is seafood, the relevance to ASH is the genus: Aeromonas is the dominant gut symbiont of medicinal leeches and the principal cause of post-hirudotherapy infection, so documentation that environmental aeromonads carry broad multidrug and ESBL resistance reinforces why empiric antibiotic prophylaxis around leech therapy must anticipate resistance and why ampicillin alone is inadequate. The honest caveat is that this work examined clam-derived isolates, not leech-associated strains or any clinical hirudotherapy case, so it is indirect, genus-level evidence rather than data on leech therapy itself.

Citation

Antibiotic and heavy metal resistance genes in Aeromonas spp. isolated from marketed Manila Clam (Ruditapes philippinarum) in Korea.

Dahanayake et al. · Journal of applied microbiology, 2019

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.